An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
2020 · Gynecologic Oncology · 46 citations
https://doi.org/10.1016/j.ygyno.2020.05.013